|
|
|
Highly active antiretroviral therapy (HAART) |
|
Histamine1 (H1) receptor antagonist, for chr(173)anaphylaxis |
|
|
|
Histamine-2 blockers, for abdominal trauma |
|
|
|
HIV |
|
HIV entry inhibitors, for HIV |
|
|
|
|
|
|
|
|
|
Human B-type natriuretic peptides |
|
|
|
|
|
|
|
|
|
Hallucinogens, signs and symptoms of withdrawal |
|
Headache, migraine |
|
Hematest, in colorectal cancer |
|
Hematological disorders, in lupus chr(173)erythematosus |
|
Hematopoietic growth factors, for chronic chr(173)kidney disease |
|
Hemoclipping, endoscopic, for Mallory-Weiss syndrome |
|
Hemodynamic monitoring, in cardiogenic shock |
|
Hemoglobin A1c, in diabetes mellitus |
|
Hemoglobin |
|
Hemophilia |
|
Hemorrhagic cystitis |
|
Hemorrhoids |
|
Henoch-Schönlein purpura |
